Shareholders Equity (Details Narrative) - USD ($) | | | | | | 1 Months Ended | 3 Months Ended | | | | |
Apr. 27, 2023 | Apr. 26, 2023 | Mar. 31, 2023 | Feb. 17, 2023 | Jan. 23, 2023 | Apr. 30, 2021 | Mar. 31, 2023 | Mar. 31, 2022 | Apr. 25, 2023 | Dec. 31, 2022 | Jun. 03, 2022 | Aug. 01, 2020 |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Common stock, par or stated value per share | | | $ 0.0001 | | | | $ 0.0001 | | | $ 0.0001 | | |
Share based compensation | | | | | | | $ 192,061 | $ 470,685 | | | | |
Issuance of common stock | | | | | | | 25,308 | | | | | |
Stockissuedduringperiod,value,newissues | | | | | | | | | | | | |
Share based payment award options and warrants outstanding intrinsic value | | | $ 0 | | | | 0 | | | $ 0 | | |
Stock compensation expense | | | | | | | $ 192,000 | | | | | |
Common stock, shares authorized | | | 50,000,000 | | | | 50,000,000 | | | 50,000,000 | | |
Preferred stock, shares authorized | | | 5,000,000 | | | | 5,000,000 | | | 5,000,000 | | |
Subsequent Event [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Stockholders' equity, reverse stock split | 1-for-8 reverse stock split | one-for-eight (1-for-8) reverse split | | | | | | | | | | |
Executives [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Stockissuedduringperiod,shares,newissues | | | | | | | 54,824 | | | | | |
Stockissuedduringperiod,value,newissues | | | | | | | $ 50,000 | | | | | |
Restricted Stock [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Unrecognized stock compensation expense related to restricted stock | | | $ 124,000 | | | | $ 124,000 | | | | | |
Weighted-average period | | | | | | | 7 months 6 days | | | | | |
Stock compensation expense | | | | | | | $ 139,000 | | | | | |
Share-Based Payment Arrangement, Option [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Weighted-average period | | | | | | | 1 year 9 months 18 days | | | | | |
Unrecognized stock compensation expense related to stock options | | | $ 135,000 | | | | $ 135,000 | | | | | |
Options Granted to Executive [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Stock compensation expense | | | | | | | 50,000 | | | | | |
Options Granted to Consultants [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Stock compensation expense | | | | | | | $ 3,000 | | | | | |
Common Stock [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Stockissuedduringperiod,shares,newissues | | | | | | | 8,393 | | | | | |
Stockissuedduringperiod,value,newissues | | | | | | | $ 1 | | | | | |
Common Stock [Member] | Subsequent Event [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Common stock, shares authorized | 50,000,000 | | | | | | | | 500,000,000 | | | |
Preferred stock, shares authorized | 5,000,000 | | | | | | | | 50,000,000 | | | |
Director [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Stock issued during period shares restricted stock award gross | | | | | | | 10,417 | | | | | |
Director [Member] | Common Stock [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Share based compensation | | | | | | | $ 40,000 | | | | | |
Underwriter [Member] | IPO [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Warrant to purchase common stock | | | 44,922 | | | | 44,922 | | | | | |
Warrants exercisable date | | | | | | | Mar. 14, 2022 | | | | | |
Warrants exercisable date | | | | | | | Sep. 14, 2026 | | | | | |
Exercise price per share | | | $ 40 | | | | $ 40 | | | | | |
Lender [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Warrants exercisable date | | | | | | Sep. 14, 2024 | | | | | | |
Exercise price per share | | | | | | $ 40 | | | | | | |
Number of warrants issued | | | | | | 13,286 | | | | | | |
Sales Agreement [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Proceeds from issuance initial public offering | | | | $ 2,096,000 | | | | | | | | |
Fixed commission rate percentage | | | | 3% | | | | | | | | |
Share based compensation | | | | $ 50,000 | | | | | | | | |
Stockissuedduringperiod,shares,newissues | | | 8,393 | | | | | | | | | |
Issuance of common stock | | | $ 26,601 | | | | | | | | | |
Sales Agreement [Member] | First Three Quarters [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Other expenses | | | | 7,500 | | | | | | | | |
Sales Agreement [Member] | Fourth Quarter [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Other expenses | | | | $ 10,000 | | | | | | | | |
Consulting Agreement [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Stock issued during period shares restricted stock award gross | | | | | 200,000 | | | | | | | |
Description of vesting rights | | | | | Within each of the aforementioned Option Agreements, 90% of the vesting is related to performance conditions and 10% time-based vesting. | | | | | | | |
First Option Agreement [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Stock issued during period shares restricted stock award gross | | | | | 62,500 | | | | | | | |
Exercise price | | | | | $ 4.80 | | | | | | | |
Expiration date | | | | | 5 years | | | | | | | |
Second Option Agreement [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Stock issued during period shares restricted stock award gross | | | | | 50,000 | | | | | | | |
Exercise price | | | | | $ 8 | | | | | | | |
Expiration date | | | | | 5 years | | | | | | | |
Third Option Agreement [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Stock issued during period shares restricted stock award gross | | | | | 50,000 | | | | | | | |
Exercise price | | | | | $ 10 | | | | | | | |
Expiration date | | | | | 5 years | | | | | | | |
Fourth Option Agreement [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Stock issued during period shares restricted stock award gross | | | | | 37,500 | | | | | | | |
Exercise price | | | | | $ 14 | | | | | | | |
Expiration date | | | | | 5 years | | | | | | | |
Consultant [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Stock issued for services | | | | | | | | 1,250 | | | | |
Sellers [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Stock issued for services | | | | | | | | 5,040 | | | | |
Think Equity LLC [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Common stock, par or stated value per share | | | | $ 0.0001 | | | | | | | | |
2020 Equity Incentive Plan [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Common Stock, Capital Shares Reserved for Future Issuance | | | | | | | | | | | | 239,155 |
2022 Equity Incentive Plan [Member] | | | | | | | | | | | | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | | | | | | | | | | | | |
Common Stock, Capital Shares Reserved for Future Issuance | | | | | | | | | | | 325,000 | |